TROUT HARRY R. III (Vice President, Finance) sold 3.2% of their position (542.00 shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $7.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2025ACC: 0002064832-25-000067
Officer· Vice President, Finance
Since Aug 2025
-542.00
Net shares
Net seller
$7.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
542.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−542.00
Price / share
$14.23
Trade value
$7.71K
% of position
3.2%
12/5/2025
16.89K→16.35K
Total
Net shares
−542.00
Net value
-$7.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | S · Sale | −542.00 | $14.23 | $7.71K | 3.2% | 16.89K | 16.35K |
| Total | −542.00 | -$7.71K | ||||||
Derivative Transactions0
No derivative transactions reported